U.S. flag

An official website of the United States government

NM_001372044.2(SHANK3):c.4613dup (p.Arg1539fs) AND Phelan-McDermid syndrome

Germline classification:
Uncertain significance (1 submission)
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003337931.2

Allele description [Variation Report for NM_001372044.2(SHANK3):c.4613dup (p.Arg1539fs)]

NM_001372044.2(SHANK3):c.4613dup (p.Arg1539fs)

Gene:
SHANK3:SH3 and multiple ankyrin repeat domains 3 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
22q13.33
Genomic location:
Preferred name:
NM_001372044.2(SHANK3):c.4613dup (p.Arg1539fs)
HGVS:
  • NC_000022.11:g.50722221dup
  • NG_070230.1:g.58005dup
  • NM_001372044.2:c.4613dupMANE SELECT
  • NM_033517.1:c.4388dup
  • NP_001358973.1:p.Arg1539fs
  • NP_277052.1:p.Arg1464Serfs
  • NC_000022.10:g.51160649dup
  • NM_001372044.1:c.4612dup
Protein change:
R1539fs
Molecular consequence:
  • NM_001372044.2:c.4613dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_033517.1:c.4388dup - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Phelan-McDermid syndrome
Synonyms:
TELOMERIC 22q13 MONOSOMY SYNDROME; 22q13.3 deletion syndrome; Chromosome 22q13.3 deletion syndrome; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0011652; MedGen: C1853490; Orphanet: 48652; OMIM: 606232

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004048370Neuberg Centre For Genomic Medicine, NCGM
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significancegermlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Neuberg Centre For Genomic Medicine, NCGM, SCV004048370.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The frameshift SHANK3 (p.Asp1538GlyfsTer12) variant has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.Asp1538GlyfsTer12 variant is novel (not in any individuals) in gnomAD Exomes and 1000 Genomes. This variant causes a frameshift starting with codon Aspartic Acid 1538, changes this amino acid to Glycine residue, and creates a premature Stop codon at position 12 of the new reading frame, denoted p.Asp1538GlyfsTer12. However since this variant is present in the penultimate exon functional studies will be required to prove protein truncation. For these reasons, this variant has been classified as Variant of Uncertain Significance (VUS).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 6, 2024